Daily Bulletin

The Times Real Estate

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Sydney Pipe Relining: The Smarter Way to Restore Infrastructure

In large-scale construction and civil works, outdated or damaged pipelines can bring operations to a halt. At Revolution Pipe Relining, we understand that time is money—especially for remedial build...

Daily Bulletin - avatar Daily Bulletin

Teleperformance (TP) Business Insights Report Reveals Key Shifts in Consumer Behaviour

TP’s Business Insights report  into consumer behaviors and preferences, taking in more than 57,000 respondents across 19 sectors, is shedding new light on how evolving channel preferences are resh...

Daily Bulletin - avatar Daily Bulletin

Navigating the Ascent: Your Strategic Guide to Executive Job Search

The air at the executive level is different. The stakes are higher, the competition more intense, and the path to your next leadership role requires a nuanced and strategic approach. Unlike more jun...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals